SCHEMBL1608396

SCHEMBL1608396

Cc1cc(F)ncc1-c1nc(-c2cnc3[nH]ccc3c2)no1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.46
▸ DHFR P00374 1/20 0.43
▸ CDK8 P49336 4/20 0.42
▸ AXL P30530 1/20 0.42
▸ PIK3CA P42336 3/20 0.41
▸ PIK3CD O00329 2/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ NUDT1 P36639 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ RIPK1 Q13546 3/20 0.40
▸ PLK4 O00444 1/20 0.40
▸ DCLK1 O15075 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ PAK4 O96013 1/20 0.40
▸ CHEK2 O96017 1/20 0.40
▸ INSR P06213 1/20 0.40
▸ CDK1 P06493 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608526 0.84 APP (0.51) APPDHFRCDK8AXLPIK3CA
SCHEMBL1607572 0.81 APP (0.47) APPDHFRCDK8AXLPIK3CA
SCHEMBL1608446 0.75 RIPK1 (0.55) APPCDK8AXLPIK3CAPIK3CD
SCHEMBL19745698 0.74 HDAC6 (0.56) CDK8AXLPIK3CAPIK3CDPIK3CB
SCHEMBL1252493 0.74 PIK3CD (0.48) APPCDK8AXLPIK3CAPIK3CD
SCHEMBL1607465 0.71 RIPK1 (0.50) APPCDK8AXLPIK3CAPIK3CD
SCHEMBL1250800 0.70 NPC1 (0.62) CDK8PIK3CDPIK3CBNPC1RAB9A
SCHEMBL1422718 0.69 CHRNB2 (0.61) CDK8AXLPIK3CAPIK3CDPIK3CB
SCHEMBL17854924 0.69 RIPK1 (0.64) APPCDK8AXLPIK3CAPIK3CD
SCHEMBL16135664 0.68 CDK8 (0.61) DHFRCDK8AXLPIK3CAPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles MERCK & CO. INC. 2011-04-07 — — US claimed
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles MERCK & CO. INC. 2011-04-07 — — US disclosed
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles MERCK & CO. INC. 2011-04-07 — — US disclosed
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles MERCK & CO. INC. 2011-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110081297-A1 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles APP, PSEN1, BACE1 APP 1/4885DHFR 3561/4885CDK8 4347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback